OTOV-501

N/A

Report date: 2024/09/29 14:52:26

Base Information

Drug NameOTOV-501
Drug Alias NameOTOV-501OTOV-501 基因编辑
ClassificationCell and gene therapy > Gene therapy > Gene editing
Mechanisms of ActionGene transference
TargetsGap junction beta-2 protein
Therapy Area/IndicationsHearing Loss
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesSuzhou Otovia Therapeutics Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSuzhou Otovia Therapeutics Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsHearing Loss
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A